Revised SPC: Plaquenil-Hydroxychloroquine sulfate tablets
SPC now adds detail with respect to several drug interactions; it can increase digoxin levels, enhance the effects of hypoglycaemic treatment and increase ciclosporin levels. It is also now contraindicated with drugs known to induce retinal toxicity, e.g. tamoxifen.
Source:
electronic Medicines compendium